% | $
Quotes you view appear here for quick access.

Chelsea Therapeutics Internation Message Board

  • mekadik007 mekadik007 May 7, 2013 1:51 PM Flag



    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • bad advice!!!! chtp is a lock for approval end of 2013. the next northera trial, post approval, will certainly have falls as secondary end point. lets not forget about ch-1504- once northera is approved, they will bring that back into the game; license it out to big pharma, run another trial, take a partner or sell the rights entirely. for all the newbies, chtp also has the i-3d portfolio. it is preclinical but has huge potential and promise! i still think they might get scooped up by a bigger company soon after northera is approved. pps will be about 5-6$ at that point which would put market cap around 400 million... what would be a fair price at that point- something where everyone is happy. 8-10 $ per share smells about right( assuming northera is approved q4 this year. orphan status makes the drug MUCH more appealing to a suitor!!!! I like an even billion for the company- about 13$ per share- would likely need euro approval as well to demand that kind of money. any real longterm longs deserve a nice payday, we have endured some hell of a rollercoaster ride the last year or two. was hard not to sell when the stock hit .70$= so i did what buffet would do......Bought MORE. .........also a good chance they take a partner to market northera in the usa( already very clear they will partner for euroupe marketing) GLTA

      Sentiment: Buy

    • ARNA is garbage, can't sell their fat pills 1.7 billion market cap and almost no sales. Why buy a bloated pig?

    • been in and finally sea lets loose. easy double if not triple coming. should have been sitting in high teens if ws didnt bet againdst it